(Q33864926)

English

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study (English)

1 reference

Europe PubMed Central

29 July 2017

1 reference

based on heuristic

inferred from title

Giuseppe Tambussi

12

object named as

Giuseppe Tambussi

1 reference

Europe PubMed Central

29 July 2017

Giovanni Paniccia

object named as

Giovanni Paniccia

7

0 references

Stefania Bellino

object named as

Stefania Bellino

1

0 references

Alessandra Latini

object named as

Alessandra Latini

17

0 references

Orietta Picconi

object named as

Orietta Picconi

3

0 references

Cecilia Sgadari

object named as

Cecilia Sgadari

6

0 references

object named as

Silvia Nozza

13

0 references

Fabrizio Ensoli

object named as

Fabrizio Ensoli

29

0 references

object named as

Paolo Monini

27

0 references

object named as

Barbara Ensoli

30

0 references

Gioacchino Angarano

object named as

Gioacchino Angarano

9

0 references

object named as

Massimo Galli

26

0 references

Adriano Lazzarin

object named as

Adriano Lazzarin

11

0 references

25

object named as

Andrea Gori

1 reference

Europe PubMed Central

29 July 2017

14

object named as

Carlo Torti

1 reference

Europe PubMed Central

29 July 2017

author name string

Antonella Tripiciano

2

1 reference

Europe PubMed Central

29 July 2017

Vittorio Francavilla

4

1 reference

Europe PubMed Central

29 July 2017

Olimpia Longo

5

1 reference

Europe PubMed Central

29 July 2017

Angela Arancio

8

1 reference

Europe PubMed Central

29 July 2017

Nicoletta Ladisa

10

1 reference

Europe PubMed Central

29 July 2017

Emanuele Focà

15

1 reference

Europe PubMed Central

29 July 2017

Guido Palamara

16

1 reference

Europe PubMed Central

29 July 2017

Laura Sighinolfi

18

1 reference

Europe PubMed Central

29 July 2017

Francesco Mazzotta

19

1 reference

Europe PubMed Central

29 July 2017

Massimo Di Pietro

20

1 reference

Europe PubMed Central

29 July 2017

Giovanni Di Perri

21

1 reference

Europe PubMed Central

29 July 2017

Stefano Bonora

22

1 reference

Europe PubMed Central

29 July 2017

Vito S Mercurio

23

1 reference

Europe PubMed Central

29 July 2017

Cristina Mussini

24

1 reference

Europe PubMed Central

29 July 2017

Aurelio Cafaro

28

1 reference

Europe PubMed Central

29 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 June 2014

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

11

1 reference

Europe PubMed Central

29 July 2017

49

1 reference

Europe PubMed Central

29 July 2017

https://scigraph.springernature.com/pub.10.1186/1742-4690-11-49

0 references

Novel biopanning strategy to identify epitopes associated with vaccine protection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Functions of Tat: the versatile protein of human immunodeficiency virus type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Tat protein induces self-perpetuating permissivity for productive HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

5 July 2018

Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency virus type 1 infection and Kaposi's sarcoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

The therapeutic phase I trial of the recombinant native HIV-1 Tat protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087126

29 October 2018

Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1742-4690-11-49

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33864926&oldid=1899120017"